Overnight closed-loop control improves glycemic control in a multicenter study of adults with type 1 diabetes

Journal of Clinical Endocrinology and Metabolism

Volumn 102, Issue 10, 2017, Pages 3674-3682

  Brown, Sue A ^a   Breton, Marc D ^a   Anderson, Stacey M ^a   Kollar, Laura ^a   Keith Hynes, Patrick ^b   Levy, Carol J ^c   Lam, David W ^c   Levister, Camilla ^c   Baysal, Nihat ^d   Kudva, Yogish C ^e   Basu, Ananda ^e   Dadlani, Vikash ^e   Hinshaw, Ling ^e   McCrady Spitzer, Shelly ^e   Bruttomesso, Daniela ^f   Visentin, Roberto ^f   Galasso, Silvia ^f   Del Favero, Simone ^f   Leal, Yenny ^f   Boscari, Federico ^f   Avogaro, Angelo ^f   Cobelli, Claudio ^f   Kovatchev, Boris P ^a   more..

^a UNIVERSITY OF VIRGINIA   (United States)

^b TypeZero Technologies   (United States)

^c MOUNT SINAI SCHOOL OF MEDICINE   (United States)

^d RENSSELAER POLYTECHNIC INSTITUTE   (United States)

^e MAYO CLINIC   (United States)

^f UNIVERSITY OF PADOVA   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

GLUCOSE; HEMOGLOBIN A1C; ANTIDIABETIC AGENT; GLUCOSE BLOOD LEVEL; GLYCOSYLATED HEMOGLOBIN; INSULIN;

ADULT; ARTICLE; CLINICAL ARTICLE; CLINICAL EFFECTIVENESS; CLINICAL PROTOCOL; CLOSED LOOP CONTROL; CONTROLLED STUDY; CROSSOVER PROCEDURE; FEMALE; GLUCOSE BLOOD LEVEL; GLYCEMIC CONTROL; HUMAN; HYPOGLYCEMIA; INSULIN DEPENDENT DIABETES MELLITUS; INTERMETHOD COMPARISON; MALE; MIDDLE AGED; MULTICENTER STUDY; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SAFETY; SENSOR AUGMENTED PUMP THERAPY; THERAPY; ANALYSIS; BLOOD; BLOOD GLUCOSE MONITORING; CIRCADIAN RHYTHM; CLINICAL TRIAL; DEVICES; DIABETES MELLITUS, TYPE 1; DRUG EFFECTS; INSULIN INFUSION; PROCEDURES; YOUNG ADULT;

ADULT; BLOOD GLUCOSE; BLOOD GLUCOSE SELF-MONITORING; CIRCADIAN RHYTHM; CROSS-OVER STUDIES; DIABETES MELLITUS, TYPE 1; FEMALE; HEMOGLOBIN A, GLYCOSYLATED; HUMANS; HYPOGLYCEMIC AGENTS; INSULIN; INSULIN INFUSION SYSTEMS; MALE; MIDDLE AGED; YOUNG ADULT;

EID: 85029889798     PISSN: 0021972X     EISSN: 19457197     Source Type: Journal    
DOI: 10.1210/jc.2017-00556     Document Type: Article

References (21)

1. Lachin JM, Genuth S, Cleary P, Davis MD, Nathan DM; Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and Complications Research Group. Retinopathy and nephropathy in patients with type 1 diabetes four years after a trial of intensive therapy. N Engl J Med. 2000;342(6):381-389.
2. American Diabetes Association. 5. Glycemic targets. Diabetes Care. 2016;39(Suppl 1):S39-S46.
3. American Diabetes Association. 11. Children and adolescents. Diabetes Care. 2016;39(Suppl 1):S86-S93.
4. Miller KM, Foster NC, Beck RW, Bergenstal RM, DuBose SN, DiMeglio LA, Maahs DM, Tamborlane WV, T1D Exchange Clinic Network. Current state of type 1 diabetes treatment in the U.S.: updated data from the T1D exchange clinic registry. Diabetes Care. 2015;38(6):971-978.
5. Brown SA, Kovatchev BP, Breton MD, Anderson SM, Keith-Hynes P, Patek SD, Jiang B, Ben Brahim N, Vereshchetin P, Bruttomesso D, Avogaro A, Del Favero S, Boscari F, Galasso S, Visentin R, Monaro M, Cobelli C. Multinight “bedside” closed-loop control for patients with type 1 diabetes. Diabetes Technol Ther. 2015; 17(3):203-209.
6. Hovorka R, Elleri D, Thabit H, Allen JM, Leelarathna L, El-Khairi R, Kumareswaran K, Caldwell K, Calhoun P, Kollman C, Murphy HR, Acerini CL, Wilinska ME, Nodale M, Dunger DB. Overnight closed-loop insulin delivery in young people with type 1 diabetes: a free-living, randomized clinical trial. Diabetes Care. 2014;37(5): 1204-1211.
7. Nimri R, Muller I, Atlas E, Miller S, Fogel A, Bratina N, Kordonouri O, Battelino T, Danne T, Phillip M. MD-Logic overnight control for 6 weeks of home use in patients with type 1 diabetes: randomized crossover trial. Diabetes Care. 2014;37(11):3025-3032.
8. Thabit H, Lubina-Solomon A, Stadler M, Leelarathna L, Walkinshaw E, Pernet A, Allen JM, Iqbal A, Choudhary P, Kumareswaran K, Nodale M, Nisbet C, Wilinska ME, Barnard KD, Dunger DB, Heller SR, Amiel SA, Evans ML, Hovorka R. Home use of closed-loop insulin delivery for overnight glucose control in adults with type 1 diabetes: a 4-week, multicentre, randomised crossover study. Lancet Diabetes Endocrinol. 2014;2(9):701-709.
9. Cobelli C, Renard E, Kovatchev BP, Keith-Hynes P, Ben Brahim N, Place J, Del Favero S, Breton M, Farret A, Bruttomesso D, Dassau E, Zisser H, Doyle FJ III, Patek SD, Avogaro A. Pilot studies of wearable outpatient artificial pancreas in type 1 diabetes. Diabetes Care. 2012;35(9):e65-e67.
10. Patek SD, Magni L, Dassau E, Karvetski C, Toffanin C, De Nicolao G, Del Favero S, Breton M, Man CD, Renard E, Zisser H, Doyle FJ III, Cobelli C, Kovatchev BP; International Artificial Pancreas (iAP) Study Group. Modular closed-loop control of diabetes. IEEE Trans Biomed Eng. 2012;59(11):2986-2999.
11. Keith-Hynes P, Guerlain S, Mize B, Hughes-Karvetski C, Khan M, McElwee-Malloy M, Kovatchev BP. DiAs user interface: a patient-centric interface for mobile artificial pancreas systems. J Diabetes Sci Technol. 2013;7(6):1416-1426.
12. Clarke WL, Cox DJ, Gonder-Frederick LA, Julian D, Schlundt D, Polonsky W. Reduced awareness of hypoglycemia in adults with IDDM: a prospective study of hypoglycemic frequency and associated symptoms. Diabetes Care. 1995;18(4):517-522.
13. Gonder-Frederick LA, Schmidt KM, Vajda KA, Greear ML, Singh H, Shepard JA, Cox DJ. Psychometric properties of the hypoglycemia fear survey-II for adults with type 1 diabetes. Diabetes Care. 2011;34(4):801-806.
14. Gonder-Frederick LA, Vajda KA, Schmidt KM, Cox DJ, Devries JH, Erol O, Kanc K, Schächinger H, Snoek FJ. Examining the behaviour subscale of the hypoglycaemia fear survey: an international study. Diabet Med. 2013;30(5):603-609.
15. Singh H, Gonder F. Assessing hyperglycemia avoidance in people with type 1 diabetes. Diabetes Manag (Lond). 2014;4:263-271.
16. Clarke W, Kovatchev B. Statistical tools to analyze continuous glucose monitor data. Diabetes Technol Ther. 2009;11(Suppl 1): S45-S54.
17. Kropff J, Del Favero S, Place J, Toffanin C, Visentin R, Monaro M, Messori M, Di Palma F, Lanzola G, Farret A, Boscari F, Galasso S, Magni P, Avogaro A, Keith-Hynes P, Kovatchev BP, Bruttomesso D, Cobelli C, DeVries JH, Renard E, Magni L; AP@home consortium. 2 month evening and night closed-loop glucose control in patients with type 1 diabetes under free-living conditions: a randomised crossover trial. Lancet Diabetes Endocrinol. 2015;3(12): 939-947.
18. Sharifi A, De Bock MI, Jayawardene D, Loh MM, Horsburgh JC, Berthold CL, Paramalingam N, Bach LA, Colman PG, Davis EA, Grosman B, Hendrieckx C, Jenkins AJ, Kumareswaran K, Kurtz N, Kyoong A, MacIsaac RJ, Speight J, Trawley S, Ward GM, Roy A, Jones TW, O'Neal DN. Glycemia, treatment satisfaction, cognition, and sleep quality in adults and adolescents with type 1 diabetes when using a closed-loop system overnight versus sensor-augmented pump with low-glucose suspend function: a randomized crossover study. Diabetes Technol Ther. 2016;18(12): 772-783.
19. Nedeltcheva AV, Imperial JG, Penev PD. Effects of sleep restriction on glucose control and insulin secretion during diet-induced weight loss. Obesity (Silver Spring). 2012;20(7):1379-1386.
20. Nedeltcheva AV, Kessler L, Imperial J, Penev PD. Exposure to recurrent sleep restriction in the setting of high caloric intake and physical inactivity results in increased insulin resistance and reduced glucose tolerance. J Clin Endocrinol Metab. 2009;94(9): 3242-3250.
21. Barnard KD, Wysocki T, Allen JM, Elleri D, Thabit H, Leelarathna L, Gulati A, Nodale M, Dunger DB, Tinati T, Hovorka R. Closing the loop overnight at home setting: psychosocial impact for adolescents with type 1 diabetes and their parents. BMJ Open Diabetes Res Care. 2014;2(1):e000025.